Literature DB >> 34341117

Growth of Mycobacterium tuberculosis at acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity.

Alexandre Gouzy1, Claire Healy1, Katherine A Black2, Kyu Y Rhee2, Sabine Ehrt3.   

Abstract

Acidic pH arrests the growth of Mycobacterium tuberculosis in vitro (pH < 5.8) and is thought to significantly contribute to the ability of macrophages to control M. tuberculosis replication. However, this pathogen has been shown to survive and even slowly replicate within macrophage phagolysosomes (pH 4.5 to 5) [M. S. Gomes et al., Infect. Immun. 67, 3199-3206 (1999)] [S. Levitte et al., Cell Host Microbe 20, 250-258 (2016)]. Here, we demonstrate that M. tuberculosis can grow at acidic pH, as low as pH 4.5, in the presence of host-relevant lipids. We show that lack of phosphoenolpyruvate carboxykinase and isocitrate lyase, two enzymes necessary for lipid assimilation, is cidal to M. tuberculosis in the presence of oleic acid at acidic pH. Metabolomic analysis revealed that M. tuberculosis responds to acidic pH by altering its metabolism to preferentially assimilate lipids such as oleic acid over carbohydrates such as glycerol. We show that the activity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is impaired in acid-exposed M. tuberculosis likely contributing to a reduction in glycolytic flux. The generation of endogenous reactive oxygen species at acidic pH is consistent with the inhibition of GAPDH, an enzyme well-known to be sensitive to oxidation. This work shows that M. tuberculosis alters its carbon diet in response to pH and provides a greater understanding of the physiology of this pathogen during acid stress.

Entities:  

Keywords:  Mycobacterium tuberculosis; acid stress; glyceraldehyde-3-phosphate dehydrogenase; lipid catabolism; metabolism

Mesh:

Substances:

Year:  2021        PMID: 34341117      PMCID: PMC8364206          DOI: 10.1073/pnas.2024571118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis.

Authors:  T Akaki; H Tomioka; T Shimizu; S Dekio; K Sato
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro.

Authors:  H BLOCH; W SEGAL
Journal:  J Bacteriol       Date:  1956-08       Impact factor: 3.490

3.  Variability in growth/no growth boundaries of 188 different Escherichia coli strains reveals that approximately 75% have a higher growth probability under low pH conditions than E. coli O157:H7 strain ATCC 43888.

Authors:  L U Haberbeck; R C Oliveira; B Vivijs; T Wenseleers; A Aertsen; C Michiels; A H Geeraerd
Journal:  Food Microbiol       Date:  2014-07-12       Impact factor: 5.516

4.  Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro.

Authors:  Omar H Vandal; Michael H Gelb; Sabine Ehrt; Carl F Nathan
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

5.  Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources.

Authors:  Jacob J Baker; Benjamin K Johnson; Robert B Abramovitch
Journal:  Mol Microbiol       Date:  2014-07-13       Impact factor: 3.501

6.  Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress.

Authors:  Wonsik Lee; Brian C VanderVen; Ruth J Fahey; David G Russell
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

7.  Subcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages.

Authors:  Daniel J Greenwood; Mariana Silva Dos Santos; Song Huang; Matthew R G Russell; Lucy M Collinson; James I MacRae; Andy West; Haibo Jiang; Maximiliano G Gutierrez
Journal:  Science       Date:  2019-06-27       Impact factor: 47.728

8.  A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy.

Authors:  Kevin Pethe; Patricia C Sequeira; Sanjay Agarwalla; Kyu Rhee; Kelli Kuhen; Wai Yee Phong; Viral Patel; David Beer; John R Walker; Jeyaraj Duraiswamy; Jan Jiricek; Thomas H Keller; Arnab Chatterjee; Mai Ping Tan; Manjunatha Ujjini; Srinivasa P S Rao; Luis Camacho; Pablo Bifani; Puiying A Mak; Ida Ma; S Whitney Barnes; Zhong Chen; David Plouffe; Pamela Thayalan; Seow Hwee Ng; Melvin Au; Boon Heng Lee; Bee Huat Tan; Sindhu Ravindran; Mahesh Nanjundappa; Xiuhua Lin; Anne Goh; Suresh B Lakshminarayana; Carolyn Shoen; Michael Cynamon; Barry Kreiswirth; Veronique Dartois; Eric C Peters; Richard Glynne; Sydney Brenner; Thomas Dick
Journal:  Nat Commun       Date:  2010-08-24       Impact factor: 14.919

9.  Production of Superoxide in Bacteria Is Stress- and Cell State-Dependent: A Gating-Optimized Flow Cytometry Method that Minimizes ROS Measurement Artifacts with Fluorescent Dyes.

Authors:  Megan E McBee; Yok H Chionh; Mariam L Sharaf; Peiying Ho; Maggie W L Cai; Peter C Dedon
Journal:  Front Microbiol       Date:  2017-03-21       Impact factor: 5.640

10.  Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific.

Authors:  Valentina Guerrini; Brendan Prideaux; Landry Blanc; Natalie Bruiners; Riccardo Arrigucci; Sukhwinder Singh; Hsin Pin Ho-Liang; Hugh Salamon; Pei-Yu Chen; Karim Lakehal; Selvakumar Subbian; Paul O'Brien; Laura E Via; Clifton E Barry; Véronique Dartois; Maria Laura Gennaro
Journal:  PLoS Pathog       Date:  2018-08-30       Impact factor: 6.823

View more
  9 in total

1.  Rv0500A is a transcription factor that links Mycobacterium tuberculosis environmental response with division and impacts host colonization.

Authors:  Yuzo L Kevorkian; Nathan J MacGilvary; David Giacalone; Calvin Johnson; Shumin Tan
Journal:  Mol Microbiol       Date:  2022-02-28       Impact factor: 3.979

Review 2.  Types and functions of heterogeneity in mycobacteria.

Authors:  Eun Seon Chung; William C Johnson; Bree B Aldridge
Journal:  Nat Rev Microbiol       Date:  2022-04-01       Impact factor: 78.297

Review 3.  Anti-tuberculosis treatment strategies and drug development: challenges and priorities.

Authors:  Véronique A Dartois; Eric J Rubin
Journal:  Nat Rev Microbiol       Date:  2022-04-27       Impact factor: 78.297

4.  The TbD1 Locus Mediates a Hypoxia-Induced Copper Response in Mycobacterium bovis.

Authors:  Ruoyao Ma; Damien Farrell; Gabriel Gonzalez; John A Browne; Chie Nakajima; Yasuhiko Suzuki; Stephen V Gordon
Journal:  Front Microbiol       Date:  2022-04-14       Impact factor: 6.064

5.  LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain.

Authors:  Francesca Boldrin; Laura Cioetto Mazzabò; Marie-Antoinette Lanéelle; Laura Rindi; Greta Segafreddo; Anne Lemassu; Gilles Etienne; Marta Conflitti; Mamadou Daffé; Alfredo Garzino Demo; Riccardo Manganelli; Hedia Marrakchi; Roberta Provvedi
Journal:  BMC Microbiol       Date:  2022-04-01       Impact factor: 3.605

6.  PrrA modulates Mycobacterium tuberculosis response to multiple environmental cues and is critically regulated by serine/threonine protein kinases.

Authors:  David Giacalone; Rochelle E Yap; Alwyn M V Ecker; Shumin Tan
Journal:  PLoS Genet       Date:  2022-08-01       Impact factor: 6.020

Review 7.  Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance.

Authors:  Amanda N Samuels; Erin R Wang; Gregory A Harrison; Joy C Valenta; Christina L Stallings
Journal:  Front Cell Infect Microbiol       Date:  2022-08-22       Impact factor: 6.073

Review 8.  A fresh look at mycobacterial pathogenicity with the zebrafish host model.

Authors:  Monica Varela; Annemarie H Meijer
Journal:  Mol Microbiol       Date:  2021-11-07       Impact factor: 3.979

Review 9.  Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in Mycobacterium tuberculosis.

Authors:  Francesca G Tomasi; Eric J Rubin
Journal:  Front Cell Infect Microbiol       Date:  2022-09-15       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.